Literature DB >> 24649172

Radical prostatectomy as radical cure of prostate cancer in a high-risk group: A single-institution experience.

Nobuki Furubayashi1, Motonobu Nakamura1, Ken Hishikawa1, Atsushi Fukuda1, Takashi Matsumoto1, Kenichi Nishiyama2, Takeharu Yamanaka3, Yoshihiro Hasegawa1.   

Abstract

This study aimed to evaluate the possibility of performing radical prostatectomy (RP) alone to achieve radical cure of prostate cancer in a high-risk group. Between August 1998 and December 2008, 436 Japanese patients underwent antegrade RP following the exclusion of 139 patients. According to the D'Amico criteria, the low-, intermediate- and high-risk groups comprised 63, 122 and 112 patients, respectively. Twenty-five patients who were classified into the high-risk group based only on T2c stage, were evaluated as a separate intermediate/high-risk group. Results of the multivariate analysis revealed that of the preoperative characteristics only a biopsy Gleason score was a significant predictor in patients with and without PSA failure (P=0.017). After a median follow-up period of 60 months, the PSA failure-free rates in the low-, intermediate-, high- and intermediate/high-risk groups were 96.5, 92.2, 76.8 and 95.0%, respectively. No statistically significant difference was detected in the high- and intermediate/high-risk groups (P=0.064). Thus, patients classified into the high-risk group based on cT2 stage only, are considered to be potentially eligible for radical treatment by surgery alone, and should not be evaluated as high-risk patients.

Entities:  

Keywords:  D’Amico classification; high-risk group; prostate cancer; prostate-specific antigen failure; radical prostatectomy

Year:  2012        PMID: 24649172      PMCID: PMC3956272          DOI: 10.3892/mco.2012.39

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  10 in total

Review 1.  The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma.

Authors:  Jonathan I Epstein; William C Allsbrook; Mahul B Amin; Lars L Egevad
Journal:  Am J Surg Pathol       Date:  2005-09       Impact factor: 6.394

2.  Outcome of patients with Gleason score 8 or higher prostate cancer following radical prostatectomy alone.

Authors:  Badar M Mian; Patricia Troncoso; Koji Okihara; Viju Bhadkamkar; Dennis Johnston; Adriana O Reyes; R Joseph Babaian
Journal:  J Urol       Date:  2002-04       Impact factor: 7.450

3.  Carcinoma of the prostate: prognostic evaluation of certain pathologic features in 208 radical prostatectomies. Examined by the step-section technique.

Authors:  D P Byar; F K Mostofi
Journal:  Cancer       Date:  1972-07       Impact factor: 6.860

4.  Predicting prostate specific antigen outcome preoperatively in the prostate specific antigen era.

Authors:  A V D'Amico; R Whittington; S B Malkowicz; M Weinstein; J E Tomaszewski; D Schultz; M Rhude; S Rocha; A Wein; J P Richie
Journal:  J Urol       Date:  2001-12       Impact factor: 7.450

5.  Predicting disease recurrence in intermediate and high-risk patients undergoing radical prostatectomy using percent positive biopsies: results from CaPSURE.

Authors:  Gary D Grossfeld; David M Latini; Deborah P Lubeck; Jeanette M Broering; Yu Ping Li; Shilpa S Mehta; Peter R Carroll
Journal:  Urology       Date:  2002-04       Impact factor: 2.649

6.  Outcome after radical prostatectomy with a pretreatment prostate biopsy Gleason score of >/=8.

Authors:  M Manoharan; V G Bird; S S Kim; F Civantos; M S Soloway
Journal:  BJU Int       Date:  2003-10       Impact factor: 5.588

7.  High-risk prostate cancer in the United States, 1990-2007.

Authors:  Matthew R Cooperberg; Janet Cowan; Jeannette M Broering; Peter R Carroll
Journal:  World J Urol       Date:  2008-03-28       Impact factor: 4.226

8.  Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

Authors:  A V D'Amico; R Whittington; S B Malkowicz; D Schultz; K Blank; G A Broderick; J E Tomaszewski; A A Renshaw; I Kaplan; C J Beard; A Wein
Journal:  JAMA       Date:  1998-09-16       Impact factor: 56.272

9.  The impact of discordance between biopsy and pathological Gleason scores on survival after radical prostatectomy.

Authors:  Stephen A Boorjian; R Jeffrey Karnes; Paul L Crispen; Laureano J Rangel; Eric J Bergstralh; Thomas J Sebo; Michael L Blute
Journal:  J Urol       Date:  2008-11-13       Impact factor: 7.450

10.  Radical prostatectomy for high-risk prostate cancer: biochemical outcome.

Authors:  Naoki Kawamorita; Seiichi Saito; Shigeto Ishidoya; Akihiro Ito; Hideo Saito; Masanori Kato; Yoichi Arai
Journal:  Int J Urol       Date:  2009-08-05       Impact factor: 3.369

  10 in total
  1 in total

1.  Is Radical Perineal Prostatectomy a Viable Therapeutic Option for Intermediate- and High-risk Prostate Cancer?

Authors:  Hye Won Lee; Hwang Gyun Jeon; Byong Chang Jeong; Seong Il Seo; Seong Soo Jeon; Hyun Moo Lee; Han Yong Choi
Journal:  J Korean Med Sci       Date:  2015-10-16       Impact factor: 2.153

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.